Ikgdar 100 mg Injection
$86.23
$71.40
Ikgdar 100 mg Injection is a targeted monoclonal antibody therapy designed to combat various immune-related conditions, particularly in the realm of oncology. This innovative treatment is primarily utilized in the management of specific cancers such as non-Hodgkin's lymphoma and chronic lymphocytic leukemia, where it helps to inhibit the growth of malignant cells by precisely targeting and neutralizing certain proteins involved in tumor progression. While Ikgdar is effective in its role, it is important for patients to be aware of potential side effects, which can include infusion reactions and an increased risk of infections due to its impact on the immune system. Healthcare providers typically monitor patients closely during treatment to ensure safety and efficacy. As with any medication, discussing your full medical history with your doctor is crucial to avoid contraindications and ensure the best therapeutic outcome. Ikgdar 100 mg Injection represents a significant advancement in cancer therapy, providing hope for patients seeking effective treatment options. Always consult with a healthcare professional before starting this medication to understand its benefits and risks fully.
Quantity
Active Pharmaceutical Ingredient
Uses
• Ikgdar 100 mg injection is commonly used in the treatment of non-Hodgkin lymphoma (NHL). This condition involves the uncontrolled growth of lymphatic cells, which can lead to various symptoms and complications. By administering Ikgdar 100 mg injection, healthcare providers aim to help control the proliferation of these abnormal cells. This treatment option can be an integral part of a comprehensive management plan for patients with NHL.
• In patients with rheumatoid arthritis, Ikgdar 100 mg injection can provide significant therapeutic benefits. This autoimmune condition causes inflammation and pain in the joints, leading to mobility issues. The use of Ikgdar 100 mg injection helps to reduce inflammation and improve joint function. As part of a broader treatment strategy, it can enhance the quality of life for those affected by rheumatoid arthritis.
• Ikgdar 100 mg injection is also indicated for the management of chronic lymphocytic leukaemia (CLL), a type of blood cancer characterized by the accumulation of abnormal lymphocytes. This injection works to target and reduce the number of these malignant cells in the bloodstream. By using Ikgdar 100 mg injection, healthcare professionals can help improve the prognosis for patients with CLL. It plays a crucial role in the overall treatment approach for this condition.
• Additionally, Ikgdar 100 mg injection is effective in treating conditions like granulomatosis with polyangiitis and microscopic polyangiitis. These are rare autoimmune disorders that cause inflammation in blood vessels, leading to various organ dysfunctions. The administration of Ikgdar 100 mg injection can help mitigate the inflammatory process and protect organ function. This makes it a valuable option for patients dealing with these complex conditions.
Benefits
Non-Hodgkin lymphoma (NHL): Non-Hodgkin's lymphoma is a form of cancer that affects the white blood cells in the body. These cells are responsible for preventing infections. Ikgdar 100 mg Injection has been demonstrated to reduce the immune response and relieve pain and inflammation. It also can kill cancer cells and prevent their further growth. To prevent the spread of infection, it is advisable to avoid crowds and to wash your hands frequently. It is recommended that patients consume an adequate quantity of fluids unless otherwise advised by their physician.
Rheumatoid arthritis: Rituximab Injection 100 mg is an immunosuppressant that is used to treat rheumatoid arthritis. It is administered in a dose and frequency that is tailored to the patient's condition. This is determined by the physician. It is crucial to adhere to the physician's instructions and to promptly report any adverse effects, including fever, chills, or other symptoms, to the physician.
Blood cancer (chronic lymphocytic leukemia): Leukemia, also known as blood cancer, is a malignant neoplasm of the hematopoietic tissues that impairs the body's ability to combat infection. Ikgdar 100 mg is a chemotherapeutic agent that kills or inhibits the proliferation of malignant cells and is effective in the treatment of leukemia. However, it is important to discuss the potential side effects and benefits of this medication with a qualified healthcare professional. It is also essential to inform your doctor of any adverse effects that may arise during treatment.
Granulomatosis with polyangiitis: Granulomatosis with polyangiitis (GPA) is a condition that causes inflammation of the blood vessels of the ears, nose, throat, lungs, and kidneys. In this condition, the blood flow to these areas may be reduced, which can lead to their damage. Ikgdar 100 mg Vial is an effective treatment that helps reduce inflammation, pain, and swelling and prevents further damage. This improves the quality of life of those affected by GPA.
Microscopic polyangiitis: Microscopic polyangiitis is an autoimmune disease that affects the small blood vessels and may be caused by an imbalance in the immune system. Ikgdar Injection reduces the immune response and improves inflammation. This helps to heal the condition and to alleviate discomfort.
Side Effects
Anti-cancer Drug Ikgdar can cause various adverse effects that can differ from one person to another. Some of the adverse effects of the drug are listed below.
Most Common Side Effects
• Low Immunity
• Nausea
• Tinnitus
• Muscle Pain and Stiffness
• Face Swelling
• Low Blood Count of White Blood Cells and Red Blood Cells
• Increase in Glucose Levels in Blood
• Headache
Common Side Effects
• Skin Reactions
• Heart Problems
• Infections
• Allergies
How To Use
The administration of Ikgdar 100 mg is typically conducted by a medical professional, such as a doctor or nurse, in a medical facility, such as a hospital or clinic. It is not advisable to administer the product independently, and it is important to adhere to the instructions provided by a qualified healthcare professional.
Safety Advice
• Alcohol: Caution should be exercised when drinking alcohol with Rituximab Injection 100 mg. Please consult your doctor.
• Kidney: Anti-cancer Drug Ikgdar is likely to be safe in patients with kidney disease. The limited data available suggest that dose adjustment of Vortuxi Solution for Infusion may not be necessary for these patients. Please consult your doctor.
• Breastfeeding: Ikgdar Injection is likely to be safe to use while breastfeeding, and limited human statistics support that the drug now no longer poses a good risk to the baby.
• Liver: Ikgdar 100 mg Vial is not recommended in patients with active liver disease or those who have had viral hepatitis. Please consult your doctor.
• Pregnancy: Ikgdar 100 mg Injection may not be safe for use during pregnancy. Although there is limited human research, animal research has shown dangerous effects on the growing baby. Your doctor will weigh up the benefits and potential risks before prescribing it to you. Please consult your doctor.
• Driving: It is not known whether Rituximab Injection 100 mg affects your ability to drive. Do not drive if you experience symptoms that affect your ability to concentrate and react.